We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.43%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$34.3B
AUM Growth
+$4.15B
Cap. Flow
+$1.92B
Cap. Flow %
5.6%
Top 10 Hldgs %
23.44%
Holding
1,439
New
97
Increased
478
Reduced
443
Closed
54

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$200M
2
AMZN icon
Amazon
AMZN
+$126M
3
DB icon
Deutsche Bank
DB
+$109M
4
ISRG icon
Intuitive Surgical
ISRG
+$92.2M
5
WFC icon
Wells Fargo
WFC
+$83.3M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$126M
2
ABT icon
Abbott
ABT
+$79.1M
3
VFC icon
VF Corp
VFC
+$49M
4
JPM icon
JPMorgan Chase
JPM
+$48.5M
5
BNTX icon
BioNTech
BNTX
+$46.9M

Sector Composition

Rank Sector Weight
1 Technology 25.97%
2 Healthcare 15.46%
3 Financials 11.88%
4 Communication Services 9.65%
5 Consumer Discretionary 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGNE icon
1301
Neurogene
NGNE
$729M
$129K ﹤0.01%
700
– –
VNET
1302
VNET Group
VNET
$2.13B
$128K ﹤0.01%
5,817
+511
+10% +$13K
FMTX
1303
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$125K ﹤0.01%
5,000
– –
DADA
1304
DELISTED
Dada Nexus
DADA
$121K ﹤0.01%
+3,852
New +$100K
RGEN icon
1305
Repligen
RGEN
$9.21B
$121K ﹤0.01%
+600
New +$116K
P
1306
Everpure Inc
P
$32.6B
$120K ﹤0.01%
6,100
– –
ANAB icon
1307
AnaptysBio
ANAB
$1.64B
$119K ﹤0.01%
4,700
– –
GOSS icon
1308
Gossamer Bio
GOSS
$86.1M
$119K ﹤0.01%
14,400
– –
INZY
1309
DELISTED
Inozyme Pharma
INZY
$119K ﹤0.01%
7,000
– –
URGN icon
1310
UroGen Pharma
URGN
$2.26B
$119K ﹤0.01%
7,700
– –
PSN icon
1311
Parsons
PSN
$4.93B
$118K ﹤0.01%
3,000
– –
AXS icon
1312
AXIS Capital
AXS
$7.43B
$117K ﹤0.01%
2,500
– –
GOTU icon
1313
Gaotu Techedu
GOTU
$444M
$117K ﹤0.01%
7,993
-118,859
-94% -$2.65M
MMI icon
1314
Marcus & Millichap
MMI
$1.16B
$117K ﹤0.01%
3,000
– –
INSP icon
1315
Inspire Medical Systems
INSP
$1.73B
$116K ﹤0.01%
600
– –
ADVM
1316
DELISTED
Adverum Biotechnologies
ADVM
$113K ﹤0.01%
3,250
-1,000
-24% -$53.9K
WOLF icon
1317
Wolfspeed
WOLF
$1.52B
$113K ﹤0.01%
1,120
– –
ANIP icon
1318
ANI Pharmaceuticals
ANIP
$1.72B
$112K ﹤0.01%
3,450
– –
CLLS
1319
Cellectis
CLLS
$278M
$108K ﹤0.01%
7,000
– –
KALA icon
1320
KALA BIO
KALA
$14.6M
$107K ﹤0.01%
8
– –
NOAH
1321
Noah Holdings
NOAH
$605M
$107K ﹤0.01%
2,194
+73
+3% +$3.23K
UNFI icon
1322
United Natural Foods
UNFI
$2.8B
$107K ﹤0.01%
2,893
– –
CRUS icon
1323
Cirrus Logic
CRUS
$6.11B
$106K ﹤0.01%
1,254
– –
FUSN
1324
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$104K ﹤0.01%
13,000
– –
CBAY
1325
DELISTED
Cymabay Therapeutics
CBAY
$104K ﹤0.01%
24,000
– –
51 52
53
54 55

Similar funds

Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

DekaBank Deutsche Girozentrale's Q2 2021 Portfolio in Review

As of Q2 2021, DekaBank Deutsche Girozentrale held 1,439 positions worth $34.3B, up 14% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

DekaBank Deutsche Girozentrale deployed $1.92B of net new capital in Q2 2021, opening 97 new positions and adding to 478 existing holdings. Its largest new stake was Stellantis: 10,647,151 shares worth $207M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Broadcom, an estimated $126M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q2 2021 buy was Stellantis: 10,647,151 shares worth $207M.
  • DekaBank Deutsche Girozentrale added most to Amazon in Q2 2021, an estimated $126M increase.
  • DekaBank Deutsche Girozentrale's biggest Q2 2021 reduction was Broadcom, cutting an estimated $126M.
  • DekaBank Deutsche Girozentrale fully exited CureVac in Q2 2021, selling an estimated $6.93M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $34.3B portfolio in Q2 2021.
  • DekaBank Deutsche Girozentrale opened 97 new positions and closed 54 in Q2 2021.
  • DekaBank Deutsche Girozentrale's portfolio value rose 14% quarter-over-quarter to $34.3B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2021, filed 5 Aug 2021.